Sun Pharmaceutical Industries on Monday mentioned it has entered right into a share buy settlement with Japan’s Daiichi Sankyo Company to acquire the latter’s 11.28% stake in Zenotech Laboratories. Sun Pharma mentioned it should pay ₹5.32 crore for the stake.The main goal of the transaction from acquirer’s perspective is to consolidate its holding in the goal firm, the Mumbai-based drug agency mentioned in a regulatory submitting.After the acquisition, Sun Pharma’s stake in Zenotech will improve from 57.56% to 68.84%, it added.The acquisition is predicted to full in 30 days.Follow and join with us on Twitter, Facebook, Linkedin, Youtube
https://health.economictimes.indiatimes.com/news/pharma/sun-to-acquire-daiichis-11-28-stake-in-zenotech/90362404
Sun to acquire Daiichi’s 11.28% stake in Zenotech, Health News, ET HealthWorld
